Concepedia

Daniel R. Goldberg

DR

20

Publications

918

Citations

16

H-Index

1993

Active since

Affiliations

Boehringer Ingelheim (United States)(Current)

Vion Pharmaceuticals (United States)

Cayman Chemical (United States)

Boehringer Ingelheim (France)

Boehringer Ingelheim (Japan)

Daniel R. Goldberg is an author at Boehringer Ingelheim (United States) specializing in drug discovery, medicine, and biochemistry.

Top concepts

MedicineBiochemistryDrug DiscoveryPharmacologyNatural SciencesMedicinal ChemistryOrganic ChemistryChemistryEngineeringPharmacotherapy

Publications per year

1993–2017

20

Publications

20

Acrylonitrile Cross-Metathesis: Coaxing Olefin Metathesis Reactivity from a Reluctant Substrate

William E. Crowe, Daniel R. Goldberg · Journal of the American Chemical Society · 1995 · 185 citations

Cross-coupling Reaction, Molecular Sciences, Engineering +14

Preparation of allylsilanes via cross-metathesis

William E. Crowe, Daniel R. Goldberg, Zhijia J. Zhang · Tetrahedron Letters · 1996 · 108 citations

Organic Chemistry, Alkene Metathesis, Enantioselective Synthesis +1

Positive Cooperativity of Product Mimics in the Asymmetric Autoinduction of Diels−Alder Reactions Catalyzed by a VAPOL−Aluminum Catalyst

Douglas P. Heller, Daniel R. Goldberg, William D. Wulff · Journal of the American Chemical Society · 1997 · 94 citations

Chemical Engineering, Cross-coupling Reaction, Engineering +13

The discovery of carboline analogs as potent MAPKAP-K2 inhibitors

Jiang‐Ping Wu, Ji Wang, Asitha Abeywardane et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 58 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +8

Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension

Robert J. Aiello, Patricia-Ann K. Bourassa, Qing Zhang et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 57 citations

Rows per page

1–5 of 20